BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29301626)

  • 1. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
    Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
    J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo malignancy in heart transplant recipients: A single center experience in Japan.
    Kimura Y; Yanase M; Mochizuki H; Iwasaki K; Toda K; Matsuda S; Takenaka H; Kumai Y; Kuroda K; Nakajima S; Watanabe T; Ikura MM; Wada K; Matsumoto Y; Seguchi O; Fukushima S; Fujita T; Kobayashi J; Fukushima N
    J Cardiol; 2019 Mar; 73(3):255-261. PubMed ID: 30587457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo malignancy after lung transplantation in Japan.
    Miyazaki T; Oto T; Okumura M; Date H; Shiraishi T; Okada Y; Chida M; Kondo T; Nagayasu T
    Gen Thorac Cardiovasc Surg; 2016 Sep; 64(9):543-8. PubMed ID: 27270709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
    Bhat M; Mara K; Dierkhising R; Watt KDS
    Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends, Risk Factors, and Clinical Outcomes of De Novo Lymphoproliferative Disorders After Heart Transplantation.
    Kim IC; Kim SH; Youn JC; Kim D; Lee S; Kim H; Kim JJ; Jung MH; Rossano JW; Cherikh WS; Kobashigawa JA; Stehlik J
    JACC Heart Fail; 2024 Feb; 12(2):395-405. PubMed ID: 38326002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National survey of de novo malignancy after solid organ transplantation in Japan.
    Miyazaki T; Sato S; Kondo T; Kusaka M; Gotoh M; Saiki Y; Ono M; Kokudo N; Enosawa S; Satoh S; Soeda E; Furukawa H; Kobayashi E; Nagayasu T
    Surg Today; 2018 Jun; 48(6):618-624. PubMed ID: 29380136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
    Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
    Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.
    Wever-Pinzon O; Edwards LB; Taylor DO; Kfoury AG; Drakos SG; Selzman CH; Fang JC; Lund LH; Stehlik J
    J Heart Lung Transplant; 2017 Apr; 36(4):407-417. PubMed ID: 27686602
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates of de novo malignancy compromise post-heart transplantation survival.
    Giuliano K; Canner JK; Etchill E; Suarez-Pierre A; Choi CW; Higgins RSD; Hsu S; Sharma K; Kilic A
    J Card Surg; 2021 Apr; 36(4):1401-1410. PubMed ID: 33567114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
    Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
    PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo head and neck cancer arising in solid organ transplantation recipients: The Asan Medical Center experience.
    Park MJ; Roh JL; Choi SH; Nam SY; Kim SY; Lee YS
    Auris Nasus Larynx; 2018 Aug; 45(4):838-845. PubMed ID: 29150348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy.
    Nasser-Ghodsi N; Mara K; Allen AM; Watt KD
    Clin Transplant; 2022 Aug; 36(8):e14714. PubMed ID: 35594161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of de novo malignancy after orthotopic heart transplantation: single-centre outcomes over 20 years.
    Bakir NH; Florea IB; Phillipps J; Schilling JD; Damiano MS; Ewald GA; Kotkar KD; Itoh A; Damiano RJ; Moon MR; Masood MF
    Eur J Cardiothorac Surg; 2023 Oct; 64(4):. PubMed ID: 37815836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
    Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between infectious event and de novo malignancy after heart transplantation.
    Bujo C; Amiya E; Hatano M; Tsuji M; Maki H; Ishida J; Ishii S; Narita K; Endo M; Ando M; Shimada S; Kinoshita O; Ono M; Komuro I
    Heart Vessels; 2021 Apr; 36(4):499-508. PubMed ID: 33140148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low incidence of malignancy in heart-transplant recipients in Taiwan: an update and comparison with kidney-transplant recipients.
    Hsu RB; Chang CI; Tsai MK; Lee PH; Chou NK; Chi NH; Wang SS; Chu SH
    Eur J Cardiothorac Surg; 2010 May; 37(5):1117-21. PubMed ID: 20045346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo malignancy post-liver transplantation: a single center, population controlled study.
    Chatrath H; Berman K; Vuppalanchi R; Slaven J; Kwo P; Tector AJ; Chalasani N; Ghabril M
    Clin Transplant; 2013; 27(4):582-90. PubMed ID: 23808800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.